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Background. Atypical response behavior on depression questionnaires may invalidate 
depression severity measurements. This study aimed to identify and investigate atypical 
profiles of depressive symptoms using a data-driven approach based on item response 
theory (IRT). 
Methods. A large cohort of participants completed the Inventory of Depressive 
Symptomatology self-report (IDS-SR) at baseline (n=2292) and two-year follow-up 
(n=1971). Person-fit statistics were used to quantify how strongly each patient’s observed 
symptom profile deviated from the expected profile given the group-based IRT model. 
Identified atypical profiles were investigated in terms of reported symptoms, external 
correlates and temporal consistency.
Results. Compared to others, atypical responders (6.8%) showed different symptom 
profiles, with higher ‘mood reactivity’ and ‘suicidal ideation’ and lower levels of mild 
symptoms like ‘sad mood’. Atypical responding was associated with more medication use 
(especially tricyclic antidepressants: OR=1.5), less somatization (OR=0.8), anxiety severity 
(OR=0.8) and anxiety diagnoses (OR=0.8-0.9), and was shown relatively stable (29.0%) 
over time.
Limitations. This is a methodological proof-of-principal based on the IDS-SR in outpatients. 
Implementation studies are needed.
Conclusion. Person-fit statistics can be used to identify patients who report atypical 
patterns of depressive symptoms. In research and clinical practice, the extra diagnostic 
information provided by person-fit statistics could help determine if respondents’ 






































Major Depressive Disorder (MDD) is a burdensome disorder with heterogeneous 
symptomatology1–3 and course trajectories4,5. This heterogeneity is a likely reason for the 
persistent lack of comprehensive etiological models for depression6. In order to improve 
this situation, researchers have attempted to identify more homogenous clinical entities 
(e.g. subtypes) that better capture the variability among depression patients in terms of 
phenomenology and etiology.
 Depression subtypes are based on clinical consensus (e.g. melancholic or atypical 
depression7) or on empirically-derived common patterns of depressive symptoms. 
The latter have been investigated with latent class analyses (LCA), which has provided 
interesting insights into the heterogeneity among depressed patients8,9. However, a 
consistent and well-replicated subtyping model to capture all their inter-individual 
differences has not yet been established10. This could be due to the limitations of LCA11, 
and sample/design inconsistencies across studies10. However, a more basal issue is that 
the models are based on subjectively reported symptoms that are all assumed to reflect 
the construct of depression, which is not necessarily true.
 Depressive symptoms can be reported for other reasons than the presence of MDD, 
such as comorbid somatic or psychiatric disorders, the presence of isolated symptoms, 
secondary gains by over- or underreporting of symptoms and the existence of specific 
subtypes of depression. This can result in atypical profiles of reported depressive 
symptoms, which means that patients with such patterns do not conform to definitions 
of depression. For instance, some depressive patients with somatic illness tend to more 
often endorse somatic-depressive symptoms, leading to patterns of reported symptoms 
that do not exclusively reflect depression severity12. This is problematic for the assessment 
of depression severity because scores of persons with atypical profiles do not adequately 
reflect the assumed underlying construct of depression and cannot be classified or scaled 
accordingly on a depression severity dimension.
The above described heterogeneity of response behavior can be investigated with a data-
driven approach based on person-fit statistics and item response theory (IRT13). Through 
person-fit statistics, researchers can investigate the extent to which a respondent’s 
observed score pattern deviates from the expected pattern based on a group-based IRT 
model14. A particular pattern of depressive symptoms can be empirically classified as 
atypical when too many unexpected scores are observed (e.g. reporting severe symptoms 
but no mild symptoms). This approach allows for a data-driven identification of atypical 
response profiles, making no a priori assumptions about what these profiles look like. As a 
result, the technique is not limited to pre-specified depression classifications or subtypes 
and could yield new insights into variations in depressive symptom reporting.
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To our knowledge, only three previous studies have used person-fit analyses in mental 
health-related research. First, Conijn et al.15 identified atypical response patterns on health-
related outcome measures among clinical outpatients. These patterns were associated 
with severe psychological distress and psychopathology, including somatoform disorders, 
psychotic disorders, and substance-related disorders. Second, Woods et al.16 found 
that atypical responding on personality questionnaires was associated with personality 
pathology. These two studies suggest that person-fit statistics can identify atypical 
response patterns that are reflective of relevant inter-individual differences and do not 
arise merely due to chance or non-systematic influences (e.g. test behavior). In a third 
study, Conrad et al.17 used person-fit analyses to screen for ‘atypical suicide risk’, using a 
questionnaire of internalizing symptoms that was administered to patients with substance-
related problems. Those that reported suicidality, but no or few other internalizing 
symptoms were identified as atypical responders. These patients reported suicidality out 
of the blue, not in the context of severe internalizing symptomatology. By identifying the 
latter group, this study showed the extra diagnostic information that person-fit statistics 
could provide on top of traditional compound scores. 
This study aimed to use person-fit analyses to investigate symptom reporting on the 
Inventory of Depressive Symptomatology Self Report (IDS-SR) in a large cohort study. 
First, person-fit statistics were used to identify persons with atypical response patterns, 
given the underlying IRT model of depression severity. Second, item-responses in the 
atypical responders were investigated. Third, associations of atypical response patterns 
with external factors were investigated. Finally, the consistency of atypical response 
behavior over time was investigated.
METHODS
PARTICIPANTS AND PROCEDURES
Data came from the Netherlands Study of Depression and Anxiety (NESDA), a large scale 
longitudinal cohort study among 2981 adult participants (aged 18-65; 1002 men, 1979 
women). Participants were recruited in the general population (19%), primary care (54%), 
and secondary care (27%). Exclusion criteria were not being fluent in Dutch and/or having 
a primary diagnosis of bipolar disorder, obsessive compulsive disorder, psychotic disorder, 
or severe addiction disorder. A follow-up assessment was conducted after two years with 
a response rate of 87.1% (n=2596). Details about the rationale, objectives, and methods of 




































 All participants had a face-to-face assessment session with a trained research 
assistant, consisting of a standardized psychiatric and demographic interview, biomedical 
measurements, a blood-draw and a battery of self-report questionnaires. The protocol of 
the NESDA study was approved by the Ethical Committees of all participating universities. 
All participants signed informed consent. 
 Data for the current study came from the baseline assessment and the two-year follow 
up. Only participants with a lifetime anxiety or depression diagnosis (n=2329; 78.1%) were 
included. Of these, 1971 (84.6%) provided follow up data. From these samples, patients 
with >5 missing values on the IDS-SR were excluded, leading to a baseline sample of 2292 
patients and a follow-up sample of 1942 patients. 
MEASURES
Depressive symptoms
The IDS-SR19 (Rush et al., 1996) is a self-report questionnaire consisting of 30 items rated 
on a 4-point (0-3) Likert scale. A participant could either endorse ‘appetite increase’ or 
‘appetite decrease’ and either ‘weight increase’ or ‘weight decrease’. Therefore, these items 
were combined respectively into compound ‘appetite change’ and ‘weight change’ items. 
The IDS-SR assesses all DSM-IV criterion symptoms for MDD and the most commonly 
associated symptoms (e.g. anxiety, irritability). 
External variables
As no previous studies investigated person-fit in depression, there were no a priori 
hypotheses about factors that might be associated with atypical depressive symptom 
reporting. Therefore, a data-mining strategy was used to investigate which out of a 
wide range of explanatory variables predicted atypical symptom reporting. The used 
external variables included socio-demographic, clinical, and biological factors. Socio-
demographic factors (gender, age, healthcare setting, years of education and north-
European ancestry) were assessed at baseline. The Composite International Diagnostic 
Interview (CIDI, WHO version 2.1) was conducted at baseline to assess the presence 
of lifetime and current (past six months) DSM-IV diagnoses of MDD, dysthymia, social 
phobia, generalized anxiety disorder, panic disorder and agoraphobia, alcohol use disorder 
(alcohol abuse/alcohol dependence). Dichotomous DSM-IV MDD subtype specifiers 
(atypical and melancholic) were derived from the IDS-SR and calculated regardless of CIDI 
diagnosis. Anxiety severity was measured with the 21-item Beck Anxiety Inventory (BAI20). 
Both the continuous total BAI score and a categorical BAI severity indicator (≥10:mild, 
≥19:moderate, ≥30:severe20) were investigated. Manic symptoms were assessed using 
the 15-item Mood Disorder Questionnaire (MDQ21). Both the continuous total scale score 
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and dichotomous indicator of positive screening (MDQ≥7) for (hypo)manic episode were 
used. Of the Four Dimensional Symptom Questionnaire (4DSQ22), the distress (16 items, 
range 0-32) and somatization (16 items, range 0-31) scales were used as continuous 
indicators. In addition, a dichotomous somatization indicator (somatization≥11) was 
used. Big-Five personality traits were assessed using the Neuroticism-Extraversion-
Openness Five-Factor-Inventory (NEO-FFI23). Past month use of soft and hard drugs was 
assessed with a self-report questionnaire. Alcohol use was assessed with the alcohol use 
disorders identification test (AUDIT24). Medication was classified according to the World 
Health Organization Anatomical Therapeutic Chemical classification25. Frequent use (daily 
or at least 50% of the time) of tricyclic antidepressants (TCA; N06AA), selective serotonin 
reuptake inhibitors (SSRI; N06AB), and other antidepressants (including monoamine 
oxidase inhibitors, nonselective [N06AF], and antidepressants classified as N06AX) as 
well as benzodiazepines (N03AE, N05BA, N05CD, and N05CF) was assessed, based on 
drug container inspection during the baseline interview. The presence of chronic somatic 
illness was assessed during the face-to-face interview, a count was made of both the 
number of present chronic illnesses and the number of chronic illnesses under treatment. 
Inflammation was also assessed as it reflects poor somatic health and is considered to be 
an important risk factor for depression26. Levels of inflammation markers C-reactive protein 
(CRP), Interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-a) were determined in 
blood samples, obtained on the day of the interview around 8:00 AM27. The inflammation 
markers were log transformed prior to analysis.
STATISTICAL ANALYSES
Missing data
In those with five or less missing responses, missing IDS-SR item scores were imputed for 
baseline (323 item scores, 0.50%) and follow-up data (133 item scores, 0.24%). Missing 
values on the external variables were imputed on scale level for baseline (1419 scale 
scores, 0.96%) and follow up data (684 scale scores, 0.35%). Imputation was performed 
using the R package ‘impute’28 using a K-nearest neighbor (KNN) search to impute missing 
values based on scores of subjects with similar symptom profiles. KNN imputation was 
chosen based on theoretical grounds because differences in symptom reporting were 
hypothesized to exist across the sample and an imputation approach based on the whole 
sample would be in contradiction with this.
Exploratory analyses
Prior to the person-fit analyses, exploratory nonparametric IRT analyses were performed 
to inspect data quality and check IRT assumptions. Nonparametric IRT analyses provide 




































Mokken scale analysis was performed to inspect IRT assumptions using MSP5.030 and 
‘mokken’ R package31. Item response behavior was visually inspected using Testgraf32. 
Unidimensionality is a key assumption of IRT. The probability of reporting a symptom 
should mainly depend on the underlying level of depression and not on other, smaller 
factors. The extent of unidimensionality was checked by fitting a bi-factor model with each 
item loading on a general factor and on a specific group factor. Previous factor analytic 
studies on the IDS-SR19,33 were used to specify the factor structure. The root mean square 
error of approximation (RMSEA) and the comparative fit index (CFI) were used to assess 
model fit, with a RMSEA<0.06 and CFI>0.95 indicating good model fit34. Two criteria were 
used to assess the unidimensionality of the data: (a) factor loadings on the general factor 
and the group factors were compared35, and (b) the explained common variance (ECV) of 
the general factors was evaluated36. These analyses were performed with the R-package 
‘lavaan’37 using adjusted weighted least squares (WLSMV) estimation. 
Person-fit analyses
The graded response model (GRM38) was fitted as IRT model. The GRM was chosen 
because the item response data consisted of ordered categorical responses reflecting 
symptom severity39. The model estimates two parameters for each item: the discrimination 
parameter (α) describes how strong a symptom (item) is related to underlying depression 
severity (person characteristic), and the threshold (β) reflects the severity of a symptom 
(item). 
Person-fit analysis using probability based IRT models enable identification of individuals 
that respond in a different way than would be expected based upon the IRT model that is 
used to describe the data40. The probability of endorsing depressive symptoms is expected 
to decrease as symptoms become more severe. In many cases, misfit is caused by the 
endorsement of severe symptoms (e.g. suicidal ideation) without endorsement of milder 
symptoms (e.g. sad mood). The more a person’s responses deviate from this pattern of 
decreasing endorsement with increasing severity, the poorer his/her person-fit. In the 
current study, the polytomous likelihood based person-fit statistic lz
41was used on baseline 
and follow-up data. The lz index represents how likely it is to observe an individual’s pattern 
of endorsed items, given the estimated IRT model. Persons with response patterns that are 
consistent with the IRT model will have higher values of lz, indicating good person fit, whereas 
persons with atypical response patterns will have low values of lz, indicating poor person fit. 
 Participants were divided into three groups based on their person-fit score: an ‘atypical’ 
group identified as participants with poor person-fit scores below a 5% significance level, 
a ‘prototypical’ group with excellent person-fit scores above a 95% significance level, 
and a ‘middle’ group containing all other participants. Because the observed person-fit 
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was not normally distributed, the 5% and 95% significance level cut-offs were obtained 
from the values corresponding to the top and bottom 5% of an empirical distribution of 
the person-fit statistic using Monte Carlo simulation (10,000 simulees) with the sample 
characteristics of the real data taken into account. 
Regularized regression
Because there was a large number of strongly inter-correlated external variables, 
conventional multivariate regression methods were inappropriate to investigate external 
correlates of atypical response patterns. Therefore, a shrinkage and variable selection 
technique called ‘elastic net’ regression was used instead42. Elastic net is a data-mining 
method that can be used to fit a prediction model with a very large number of predictors. 
A penalty is applied to the coefficients of the fitted model to shrink the coefficients of 
predictors with small effects to zero and to reduce their variance. In this way, all irrelevant 
effects are shrunk to zero and the most important predictors are selected from the initial 
large set of predictors. Fivefold cross validation across randomly selected subsamples 
was performed varying the tuning parameter (alpha) that controls the strength of the 
penalty (between 0=low penalty and 1=high penalty) to find the shrinkage that yielded 
the lowest cross-validated error, and thus, the most accurate cross-validated model. The 
selected regression coefficients were exponentiated to create odds-ratios.
RESULTS
DESCRIPTIVES
Baseline sample descriptives are shown in Table 1. The mean age was 42.2 (range 18-65), 
and 67.9% was female. Of the patients, 51.4% had a CIDI diagnosis of a mood disorder 
(MDD or dysthymia) and 55.9% of any anxiety disorder. At two-year follow-up (n=1942), 
the mean age was 44.4 (range 19-68) and 68.0% was female. In addition, the rates of CIDI 
mood disorders (30.0%) and anxiety disorders (34.2%) were lower than at baseline. 
EXPLORATORY ANALYSES
Nonparametric IRT analyses showed violations of model assumptions caused by rank-
order problems. For some items, the higher categories were equally or more often endorsed 
than lower categories. Item functioning improved when items were recoded from four to 
three categories. After this rescoring, unsatisfactory response behavior was still observed 
for items 1-4 (‘onset insomnia’, ‘mid insomnia’, ‘morning insomnia’ and ‘hypersomnia’) 




































TABLE 1. Descriptive characteristics of baseline sample (n=2292).
Characteristic N (%) Mean (SD)
Demographics
Female gender 1557 (67.9%)
North European ancestry 2167 (94.5%)
Secondary care 975 (42.5%)
Age (years) 42.2 (12.6)








4DSQ – Somatization 13.6 (9.7)
4DSQ – Distress 35.3 (14.1)
Audit score 4.8 (5.0)
BAI score 14.4 (10.7)
IDS score1 25.2 (13.4)
MDQ score 5.2 (3.2)
Alcohol disorders2
Alcohol abuse 264 (11.5%)






Social phobia 656 (28.6%)
GAD 452 (19.7%)







Other antidepressants 164 (7.2%)
Inflammation markers3
C-reactive protein (mg/l) 1.31 (0.56-3.11)
Interleukin-6 (pg/ml) 0.78 (0.50-1.28)
Tumor necrosis factor-alpha (pg/ml) 0.80 (0.60-1.10)
SD, standard deviation.
1 IDS sum score of original non-rescored data.
2 CIDI diagnosis of current DSM-IV disorders (during past six months).
3 Median and interquartile range of non-transformed inflammation markers.
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The bi-factor model showed good fit to the data (CFI=0.99; RMSEA=0.03), with a strong 
general factor of 0.35 (range=0.19-0.50), considerable smaller loadings on the group-
factors (average=0.10; range=-0.12-0.32) and an explained common variance (ECV) of 
0.84. This indicated that most covariance was explained by the general factor and the 
data was sufficiently unidimensional for IRT analyses.
PERSON-FIT
The distribution of the person-fit scores (Figure 1) was skewed to the left, but had quite a 
uniform shape across different levels of depression severity, with slightly poorer person-fit 
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FIGURE 1. Distribution of person-fit scores, frequencies (left) and across different levels of depression 
severity (right) with the dotted line representing the empirically derived 5% person-fit cutoff (lz=-1.39) 
for the atypical group.
To investigate what low person-fit means in practice, the response patterns and overall 
characteristics of the seven persons with the lowest person-fit scores (lz<-4) are described 
in detail in Table 2. Inspection of these cases showed that their response patterns were 
characterized by (a) extreme scores and (b) reporting of severe symptoms but no milder 
symptoms. For example, patient 1145 with poor person-fit reported the following atypical 
symptom pattern (items ordered by increasing severity): 00022122200120220002000. 
This person often endorsed either the lowest (0) or highest (2) category and endorsed 
severe symptoms without endorsing milder symptoms, which is not in line with the 
underlying depression construct. In contrast, the person with the highest person fit (lz=2.7) 
showed the following response pattern: 22111111111111111110100. This person gave 




































endorsed symptoms, in line with the underlying construct. Taken together, these results 
illustrate how (low) person-fit is indicative of unexpected atypical response behavior on 
the IDS-SR. 
TABLE 2. Example cases of patients with atypical profiles of depressive symptoms as identified by 
poor person-fit scores. The seven patients with person-fit scores on lz below -4 are reported.
Patient lz Age Gender IDS Description
568 -4.1 38 Female 42 Reports many depressive symptoms including severe symptoms 
like ‘suicidal thoughts’ but does not report core symptoms ‘sad 
mood’ and ‘capacity of pleasure’. Has a high IDS total score (42) 
indicative for severe depression, but has no CIDI diagnosis of 
MDD or dysthymia (current nor lifetime). The patient has three 
CIDI anxiety diagnoses past month (social phobia, panic with 
agoraphobia and generalized anxiety disorder) and scores high 
on the BAI (61).
1974 -4.2 58 Female 36 Scores low on mild symptoms, but high on severe symptoms 
‘suicidal thoughts’ and ‘weight gain’. Has a recurrent MDD with 
melancholic features, reported to have 4 previous episodes of 
MDD and is using tricyclic antidepressants.
592 -4.4 42 Female 19 Reports 0 on most items including ‘sad mood’ but scores high on 
somatic related symptoms. Has a high score of 18 on the 4DSQ 
somatization subscale and reports four chronic illnesses of 
which two under treatment.
935 -4.5 45 Female 32 Scores low on most symptoms including ‘sad mood’ but scores 
high on ‘reactivity of mood’, ‘quality of mood’, and ‘suicidal 
thoughts’. Is diagnosed with MDD, social phobia, panic with 
agoraphobia, generalized anxiety disorder past month and CIDI 
alcohol disorder.
1145 -4.5 41 Male 31 The patient shows a pattern of extreme scores with high scores 
on all mood and anxiety related symptoms and low scores on 
all somatic related symptoms. The patient is diagnosed with a 
recurrent MDD and reports to have had 50 MDD episodes during 
lifetime.
61 -4.7 42 Male 17 Reports only high on a few symptoms including ‘sad mood’, 
‘reactivity of mood’, ’quality of mood’ and ‘weight change’. Has a 
low IDS sum score of 17 indicating no depression, but has a CIDI 
diagnosis of MDD past month.
2936 -4.8 25 Male 26 Patient reports extreme with 0 on most symptoms and only high 
on a few symptoms ‘sad mood’, ‘quality of mood’, ‘reactivity 
of mood’, and ‘panic’. Patient is diagnosed CIDI MDD with 
melancholic features and dysthymia past month. 
PERSON-FIT SUBGROUPS
An atypical group (n=156, 6.8%) was identified with person-fit scores below the empirically 
derived 5% person-fit cutoff (lz=-1.39), and a prototypical group (n=332, 14.4%) with 
person-fit scores above the 95% person-fit cutoff (lz=1.47). The middle group (lz=-1.39 and 






























































































































































































































































FIGURE 2. Differences in symptom profiles between the atypical, middle and prototypical group. The 
groups are defined based on their person-fit scores: the atypical group has poor person-fit (lz<-1.39), 
the prototypical group has excellent person-fit (lz>1.47) and the middle group has scores in between 
(-1.39<lz<1.47). The top panel shows mean item scores for the atypical, middle and prototypical 
group. The middle and lower panel show mean item scores and mean differences for the atypical and 
non-atypical group (middle and prototypical combined).
Mean item scores of the atypical group differed substantially from the middle and 
prototypical group (Figure 2). Persons with atypical response patterns had lower mean 
scores on the items ‘irritable’, ‘anxious’, ‘somatic complaint’, and ‘leaden paralysis’ 




































ideation’, and ‘psychomotor slowing’. Mean differences on core depression symptoms 
like ‘sad mood’, ‘involvement’ and ‘concentration’ were minimal. Interestingly, the atypical 
groups’ mean item scores on ‘reactivity of mood’ (0.81) and ‘suicidal ideation’ (0.78) were 
even higher than the mean score on the core symptom ‘sad mood’ (0.75). Mean differences 
between the atypical and prototypical groups were larger than between the atypical and 
middle group, but showed similar qualitative patterns of item-score differences.
EXTERNAL VARIABLES
The regularized regression results are shown in Table 3. Linear elastic-net regression with 
continuous person-fit as outcome selected 17 out of 52 variables into a prediction model 
(regression coefficients of -0.27 to 0.37). Logistic elastic net regression with atypical 
group membership as outcome selected 16 variables into a prediction model (OR=0.6-
1.5). When using prototypical group membership as outcome, 17 variables (OR=0.5-1.5) 
were selected. Predictors selected in all three models that were associated with atypical 
group membership, included the presence of melancholic features (OR=1.2) and atypical 
features (OR=1.2), first MDD onset longer than a year ago (OR=1.1), and medication use 
(OR 1.1-1.5). The predictors North-European ancestry (OR=0.6), female gender (OR=0.8), 
somatization (OR=0.8), anxiety severity (OR=0.8) and anxiety diagnoses (OR 0.8-0.9) 
showed negative associations with atypical group-membership in all models. Interestingly, 
TNF-α was positively associated with both atypical profiles (OR=1.1) and prototypical 
profiles (OR=1.1). Together, these results indicated that the extent of atypical response 
behavior on the IDS-SR is predicted by a combination of socio-demographic, psychiatric 
and biological external characteristics.
PERSON-FIT CONSISTENCY ON FOLLOW-UP
Person-fit at baseline and follow-up correlated positively (r=0.36). In addition, the 
empirically derived cutoffs were comparable between baseline and follow-up for atypical 
(lz=-1.37) group membership, and slightly lower at follow-up for prototypical (lz=1.36) 
group membership. The identified atypical group was slightly larger at follow-up (n=158, 
8.0%) and the prototypical group was smaller (n=138, 7.1%). From the 156 patients that 
were in the atypical group at baseline, 126 (80.7%) provided data at follow up. Of these, 37 
(29%) were again in the atypical group at follow-up. The qualitative patterns of differences 
between the mean item scores in the atypical, middle and prototypical groups at follow-
up were comparable to those at baseline. Again, persons in the atypical group scored 
considerably lower than the middle and prototypical group on ‘irritable’, ’anxious’ and 
considerably higher on ‘mood reactivity’ and ‘suicidal ideation’. 
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IDS Total score4 0.02 1.0 1.0
Melancholic features 0.04 1.2 0.8
Atypical features 0.21 1.2 0.5
Demographics Female gender -0.07 0.8 1.1
Healthcare setting 0.05 1.1
North-European ancestry -0.27 0.6 1.2
Chronic illness Chronic illness (total) 0.03 1.1
Chronic illness (under treatment) 0.9
4DSQ Somatization score ≥11 -0.11 0.8 1.3
BAI Anxiety score ≥8 -0.26 0.8 1.5
MDQ MDQ Bipolar ≥7 1.1
Alcohol disorders Alcohol dependence 0.9
Alcohol abuse 1.1
Mood disorders Dysthymia (current) 0.9
MDD (lifetime) -0.15 0.8 1.2
Recurrent MDD 1.1
Onset first MDD episode (>12M) 0.10 1.1 0.8
Anxiety disorders Agoraphobia (<6M) 0.8
Social phobia (lifetime) -0.06 0.9 1.1
Panic disorder (<6M) 0.9 0.8
Panic disorder (lifetime) -0.06
Medication use Benzodiazepines 1.2
TCA 0.37 1.5 0.6
SSRI 0.03 1.1 0.9
Other Antidepressant 0.15 1.2
Biological TNF-α
1 Elastic net regression models based on tuning and shrinkage parameter that gave the lowest five-fold cross 
validated error. Not all investigated predictors were selected by the models (e.g. age, education level, personality, 
inflammation markers CRP and IL-6 were not selected in any model). No confidence intervals are reported due to 
the bias in standard errors produced by these models.  
2 Linear regression with lz person-fit negated as outcome variable, such that positive coefficients indicate the 
prediction of atypical response patterns.
3 Logistic regression for groups defined by comparing person-fit scores to the empirical derived cutoffs for atypical 
(lz < -1.39) and prototypical (lz > 1.46). Odds-ratios are reported.






































This study aimed to identify and investigate patients with unexpected, atypical profiles 
of reported depressive symptoms using a data-driven approach based on person-fit 
statistics. Using person-fit, a group of atypical responders on the IDS-SR was identified. 
Inspection of individual cases and their characteristics showed different types of atypical 
response profiles, each with unique descriptions and potential explanations for the atypical 
responding. Comparison of the item score patterns between the atypical, middle, and 
prototypical groups showed clear qualitative differences, with the atypical group reporting 
high on severe symptoms (e.g. ‘mood reactivity’ and ‘suicidal ideation’) while scoring low 
on mild symptoms (e.g. ‘sad mood’). Additional analyses showed that atypical symptom 
profiles were associated with socio-demographic (e.g. gender), clinical (e.g. medication 
use) and biological (e.g. TNF-α) factors.  Person-fit scores at follow-up were positively 
correlated with person-fit scores at baseline and a considerable number of atypical 
responders at baseline were also in the atypical group at follow-up.
 Case descriptions of the seven patients with poorest person fit confirmed that low 
person-fit scores are indicative of a variety of depressive symptom profiles that do 
not adhere to the underlying depression severity model. Several response-behavior 
characteristics could be noted from these case descriptions. First, the item-scores 
suggested that IDS total scores were not likely to reflect depression severity, limiting 
clinical interpretability. For example, one patient reported a high IDS sum score of 42, 
indicative of depression, but had no CIDI MDD diagnosis. Conversely, another patient had 
a low IDS sum score of 17 but also a current MDD diagnosis (past month) according to 
the CIDI. Second, for each atypical case, possible explanations could be found for the 
observed inconsistencies in symptom profiles. However, these explanations differed 
across patients and were specific to particular response patterns. The results indicate 
that external factors are associated with atypical depressive symptom reporting and 
that identification of patients with such profiles could help when trying to distinguish 
between those who report symptoms in the context of depression and those who do 
so for other reasons. Third, several of the investigated atypical cases showed symptom 
profiles with extreme scores and endorsed severe symptoms (e.g. mood reactivity, suicidal 
ideation) without endorsing milder symptoms (e.g. sad mood, capacity of pleasure). 
 Although the individual cases with the poorest person-fit showed very distinct case 
descriptions, group-level comparisons of item score patterns did reveal clear differences 
between the atypical and the other subgroups. The strongest differences were observed 
for items ‘mood reactivity’ and ‘suicidal ideation’, which were more often endorsed in the 
atypical group. This pattern could be explained in different ways. Mood reactivity in the 
absence of milder symptoms could be an early sign of depression relapse/remission43. 
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Reporting suicidal ideation in the absence of milder symptoms fits in with previous findings 
about atypical suicide risk17, which is considered a subtype of suicide risk where patients 
report suicidal ideation in isolation from other depressive symptoms (e.g. no sad mood). 
Detection of patients at risk of relapse and/or suicide risk is important and the person-fit 
statistic could be a useful tool to do this.
Patients in the atypical group scored lower on items ‘anxiety’, ‘irritability’, and ‘somatic 
complaint’. Also, anxiety diagnoses, BAI anxiety score, and 4DSQ somatization score were 
negatively associated with atypical response behavior. This could be explained by the fact 
that symptoms of anxiety and somatization are frequently observed in patients with MDD, 
and therefore obtain lower thresholds in the IRT model44. For most patients, reporting mild 
anxiety or somatization merely results in a slightly higher score on the underlying latent 
trait (depression severity), and does generally not result in atypical profiles. However, in 
some cases (e.g. patient 568) severe anxiety or somatization can result in atypical profiles 
when severe symptoms (e.g. suicidal ideation) but no mild depressive symptoms (e.g. sad 
mood) are reported.
The use of psychoactive medication was found to be associated with atypical depressive 
symptom profiles. This could be explained by the asymmetrical effects of medication on 
depressive symptoms. For instance, antidepressants may primarily elevate mood, with 
improvement of other symptoms as a secondary consequence45. As a result, a patient may 
report improvement on milder symptoms but less so on severe symptoms, which respond 
slower to medication. Also, the strong association of person fit with TCAs may be explained by 
the fact that patients who are prescribed TCAs are usually complex and difficult to treat cases46. 
 Interestingly, the inflammation marker TNFα was predictive of both atypical and 
prototypical profiles. The effect is small but could be explained by the fact that heightened 
levels of inflammation are on the one hand associated with antidepressant use27, which 
was found to be associated with atypical responding, and on the other hand with 
somatization26, which was found to be associated with prototypical responding.
The person-fit statistic showed considerable consistency over time. Person-fit scores 
were positively correlated between baseline and two-year follow-up, the item-score 
patterns were similar and a substantial part of the baseline atypical subgroup also showed 
an atypical profile at follow-up. This consistency of person-fit is remarkable given the fact 
that it is merely a statistic to quantify deviations from an IRT model and the considerable 
follow-up period. The finding that person-fit is consistent for a considerable number of 
patients could indicate that their atypical reporting is related to a trait-like pathology that 




































This study has several strengths, including the large sample size, the use of advanced 
psychometric techniques, the use of a large range of external variables, and the possibility 
to investigate consistency over time. However, there were also limitations. First, the 
study excluded several psychopathological conditions (e.g. bipolar disorder47). Second, 
the results are based on the IDS-SR and their generalizability to other instruments 
needs to be evaluated. Third, the results apply to depressive outpatients with relatively 
mild symptomatology and cannot be generalized to other populations (e.g. depressive 
inpatients). Fourth, although the external associates of atypical symptom reporting 
were thoroughly investigated, these group-based results only tell part of the story. The 
case descriptions of the patients with the poorest person-fit scores showed that each 
person had unique characteristics, illustrating how heterogeneous the group of atypical 
responders actually is and suggesting that variation in response behavior can only be 
partly explained on the group-level. This could be problematic for the investigation of 
potential causes of atypical responding. However, it is important to realize that irrespective 
of the cause of atypical responding, patients identified with atypical response patterns 
have total scores that are not a valid reflection of depression severity. Finally, the current 
study is a methodological study. Person-fit statistics seem promising and potentially 
clinically relevant, but a clinical field study is needed to further evaluate its practicality and 
acceptability in practice.
In conclusion, a data-driven approach was shown to be useful for the identification of 
patients who report atypical profiles of depressive symptoms on the IDS-SR. Person-fit 
statistics allowed for a novel and interesting approach to investigate the heterogeneity 
of depression by decomposing the sample into those with typical and atypical response 
profiles. Results show that a range of factors influence the reporting of depressive 
symptoms, which can lead to atypical profiles that do not conform to models of depression, 
and cannot be scaled or classified accordingly. When using depression questionnaires 
to assess their patients, clinicians could potentially use person-fit statistics to detect 
atypical responding. For example, person-fit could be computed for each patient who 
completes a computer-administered depression questionnaire. A warning could be given 
if the reported symptom pattern is potentially atypical, given the underlying depression 
construct. Clinicians can then closer inspect the item scores and augment the assessment 
with additional information about the patient to judge whether a depression scale score is 
a valid reflection of underlying symptomatology. 
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